# Terumo acquires Quirem Medical for up to $45M

Terumo has completed the acquisition of Quirem Medical, a Netherlands-based developer of microspheres for liver cancer treatment. Terumo paid $20 million upfront with up to $25 million in milestone payments by 2030.

- Type: Acquisition
- Announced: 2020-07-17
- Where: Netherlands
- Value: $45.0M
- Status: completed
- Products: microspheres for selective internal radiation therapy, holmium-166 microspheres, dosimetry software
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Terumo](https://endata.com/companies/2811.md) (acquirer)
- [Quirem Medical](https://endata.com/companies/48657.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/terumo-acquires-quirem-medical-for-up-to-45m/), 2020-07-17: "The acquisition of Quirem Medical further strengthens our business, expands on our manufacturing and clinical development activities, and complements our comprehensive suite of offerings to support our customers."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.